Faron Pharmaceuticals Limited (AIM:FARN, OTC:FPHAF) chief financial officer James O'Brien speaks to Proactive on his second day in the new role.

O'Brien reveals more about what he believes he can bring to Faron, highlighting his experience in the US capital markets.

He adds that Faron is now moving "into [its} next phase of growth."

Contact Details

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com